The estimated Net Worth of Shervin J Korangy is at least $276 Mille dollars as of 17 May 2021. Mr. Korangy owns over 6,750 units of Motus GI Inc stock worth over $1,098 and over the last 7 years he sold MOTS stock worth over $274,995. In addition, he makes $0 as Independent Director at Motus GI Inc.
Shervin has made over 2 trades of the Motus GI Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he sold 6,750 units of MOTS stock worth $274,995 on 17 May 2021.
The largest trade he's ever made was buying 20,000 units of Motus GI Inc stock on 16 February 2018 worth over $100,000. On average, Shervin trades about 1,574 units every 70 days since 2018. As of 17 May 2021 he still owns at least 35,431 units of Motus GI Inc stock.
You can see the complete history of Mr. Korangy stock trades at the bottom of the page.
Shervin J. Korangy serves as Independent Director of the Company. Mr. Korangy has served on our Board since March 2017. Mr. Korangy also serves as the Chief Financial Officer and Head of Strategy of Beaver-Visitec International (“BVI”), a leading global developer, manufacturer and marketer of specialized surgical devices for the ophthalmic marketplace. From 2012 to 2017, Mr. Korangy served in various country General Management roles for Novartis Group AG (NYSE: NVS), a global healthcare company, where he worked with medical device, pharmaceutical and consumer health product segments. Prior to that, while part of Novartis Group AG from 2010 to 2012, Mr. Korangy was the Global Head of Corporate Finance, where he was responsible for global M&A, strategy, integrations, BD&L and portfolio planning. He served on the Novartis Finance Leadership Team and the Global Deal Committee. From 1996 to 2010, Mr. Korangy worked in the Private Equity and Restructuring Advisory divisions of the Blackstone Group (NYSE: BX), where he most recently was a Managing Director. Mr. Korangy is a current member of the Board of Directors (and Chairman of the audit committee) of The Hain Celestial Group (NASDAQ: HAIN), a leading organic and natural products company, and a senior advisor to Sight Sciences LLC, a medical device growth stage business. Mr. Korangy is a former member of the Board of Directors of Pelican Rouge, a consumer coffee manufacturer and vending business, Ultra Music, an electronic and dance music record label, Graham Packaging, a manufacturer and distributer of custom plastic containers for consumer product companies, Pinnacle Foods (NYSE: PF), a consumer packaged foods manufacturer and distributer and Bayview Financial, an asset manager and loan servicer. Mr. Korangy received his B.S. degree in economics at the Wharton School of the University of Pennsylvania.
Shervin Korangy is 45, he's been the Independent Director of Motus GI Inc since 2017. There are 9 older and 1 younger executives at Motus GI Inc. The oldest executive at Motus GI Holdings Inc is Samuel Nussbaum, 71, who is the Independent Director.
Shervin's mailing address filed with the SEC is C/O THE HAIN CELESTIAL GROUP, INC., 221 RIVER STREET, 12TH FLOOR, HOBOKEN, NJ, 07030.
Over the last 7 years, insiders at Motus GI Inc have traded over $2,638,819 worth of Motus GI Inc stock and bought 3,952,265 units worth $13,986,863 . The most active insiders traders include Advisors Llcperceptive Life..., Larry Noracle Partners Lp F... e David P Hochman. On average, Motus GI Inc executives and independent directors trade stock every 33 days with the average trade being worth of $4,105. The most recent stock trade was executed by Andrew Lawrence Taylor on 19 November 2021, trading 2,000 units of MOTS stock currently worth $1,020.
motus gi holdings, inc. (nasdaq: mots) is a medical technology company based in the u.s., with subsidiaries in the u.s. and israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. the company is focused on the development and commercialization of the pure-vu® system, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. the pure-vu® system is a 510(k) u.s. food and drug administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. the device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. the pure-vu® system has received ce mark approval in europe.
Motus GI Inc executives and other stock owners filed with the SEC include: